TheVerge
An ingredient mix-up at a Baltimore manufacturing plant ruined 15 million doses of the Johnson & Johnson COVID-19 vaccine, The New York Times reported. That could delay future shipments of this vaccine in the United States.
There are not any problems with the doses of the Johnson & Johnson vaccine that have already been delivered — those were produced in the Netherlands, the Times reported. But the tens of millions of the shots set to ship in April were supposed to come from this Baltimore plant.
The manufacturing plant, run by Emergent BioSolutions, received $628 million from the Trump administration last year to expand its vaccine manufacturing capacity. The plant was still awaiting Food and Drug Administration authorization of its…
Source: TheVerge